Electromed (NYSE:ELMD) Trading Down 5.2% – Should You Sell?

Shares of Electromed, Inc. (NYSE:ELMD) traded down 5.2% during mid-day trading on Tuesday . The company traded as low as $23.07 and last traded at $23.15. 78,148 shares changed hands during mid-day trading, an increase of 4% from the average session volume of 74,962 shares. The stock had previously closed at $24.41.

Analyst Upgrades and Downgrades

Several brokerages have recently issued reports on ELMD. Zacks Research cut Electromed from a “strong-buy” rating to a “hold” rating in a report on Thursday, January 29th. Roth Mkm reissued a “buy” rating and set a $38.00 target price on shares of Electromed in a research note on Wednesday, February 11th. One investment analyst has rated the stock with a Strong Buy rating, two have given a Buy rating and one has assigned a Hold rating to the company. According to MarketBeat, the company presently has a consensus rating of “Buy” and an average price target of $36.67.

Electromed Trading Down 5.2%

The company has a market capitalization of $191.57 million, a PE ratio of 30.87 and a beta of 0.26. The business has a fifty day moving average of $27.75 and a 200 day moving average of $25.72.

Institutional Trading of Electromed

Institutional investors and hedge funds have recently bought and sold shares of the business. Kestra Advisory Services LLC acquired a new stake in shares of Electromed in the 4th quarter worth $29,000. Police & Firemen s Retirement System of New Jersey purchased a new stake in Electromed during the second quarter worth $32,000. Financial Consulate Inc. acquired a new stake in Electromed in the 3rd quarter valued at about $37,000. Thurston Springer Miller Herd & Titak Inc. purchased a new position in shares of Electromed during the 4th quarter worth approximately $43,000. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. purchased a new position in Electromed during the second quarter worth $83,000. Hedge funds and other institutional investors own 40.82% of the company’s stock.

Electromed Company Profile

Electromed Inc (NYSE: ELMD) develops and manufactures sleep therapy products designed to support individuals with breathing disorders such as obstructive sleep apnea. The company’s core business activities include the design, production and distribution of continuous positive airway pressure (CPAP) and bilevel positive airway pressure (BiPAP) accessories. Electromed’s focus on supplying both disposable and reusable components allows durable medical equipment providers to offer comprehensive therapy solutions to patients.

The company’s product portfolio encompasses masks, mask cushions, headgear, tubing, filters and humidification components.